Maximizing the benefits of using biosimilars in Egypt.

Background: Biosimilars constitute a pathway for sustainable financing of healthcare systems in the era of expensive biologics. However, such a pathway is not free of challenges. Since the biosimilars market is expanding in Egypt, there is an urgent need for a policy framework to optimize their use and diffusion in the market.

Social and self-stigma during COVID-19 pandemic: Egyptians' perspectives.

Background: Social stigma associated with infectious diseases existed throughout the history of pandemics due to fears of contagion and death. This study aims to assess social and self-stigma resulting from COVID-19 infection and other associated factors in Egypt during the pandemic.

Methods: A cross-sectional study was conducted on 533 adult Egyptians via an online questionnaire.

Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan.

Objectives: Health technology assessment (HTA) can increase the appropriateness and transparency of pricing and reimbursement decisions. Jordan is still in the early phase of its HTA implementation, although the country has very limited public resources for the coverage of healthcare technologies. The study objective was to explore and validate priorities in the HTA road map for Jordan and propose to facilitate the preferred HTA status.